Asymmetric Synthesis and CatalysisSynthesis and Characterization of Heterocyclic CompoundsSynthesis and Reactivity of HeterocyclesChemical Synthesis and ReactionsQuinazolinone synthesis and applications
Publications
81
Citations
1,882
Est. group size
—
Recurring co-author estimate
Active years
38
Publishing since 1988
Publication cadence
Publications per year over the last 10 years — averaging 0.8/year recently
Recent publications
- Structural basis for GPR40 allosteric agonism and incretin stimulation
Nature Communications · 2018
- Discovery of LY3104607: A Potent and Selective G Protein-Coupled Receptor 40 (GPR40) Agonist with Optimized Pharmacokinetic Properties to Support Once Daily Oral Treatment in Patients with Type 2 Diabetes Mellitus
Journal of Medicinal Chemistry · 2017
- The Role of GPR40 (FFAR1) in Pharmacological vs Physiological Control of Incretin Secretion
The FASEB Journal · 2017
- The Discovery, Preclinical, and Early Clinical Development of Potent and Selective GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus (LY2881835, LY2922083, and LY2922470)
Journal of Medicinal Chemistry · 2016
- A selective GPR40 (FFAR1) agonist LY2881835 provides immediate and durable glucose control in rodent models of type 2 diabetes
Pharmacology Research & Perspectives · 2016
- 2型糖尿病治療のための強力な選択的GPR40作動薬(LY2881835,LY2922083,LY2922470)の発見,前臨床及び初期臨床開発
Journal of Medicinal Chemistry · 2016
Publishes in
- Journal of Medicinal Chemistry×3
- Nature Communications×1
- Science Translational Medicine×1
- Pharmacological Research×1
- Pharmacology Research & Perspectives×1
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 9, 2026.
Claim or correct this profile